 | • レポートコード：GIR-107A12379 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、In Vivo毒性学のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。In Vivo毒性学の種類別市場規模（慢性毒性試験、亜慢性毒性試験、亜急性毒性試験、急性毒性試験）、用途別市場規模（免疫毒性、全身毒性、発がん性、遺伝子毒性、発生毒性・生殖毒性（DART）、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・In Vivo毒性学の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Thermo Fisher Scientific、Danaher、Charles River Laboratories、Labcorp、The Jackson Laboratory、Data Sciences International、Envigo、Eurofins Scientific、Perkinelmer、SRI International、Taconic Biosciences、Wuxi Apptec ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：慢性毒性試験、亜慢性毒性試験、亜急性毒性試験、急性毒性試験 ・用途別分析2016年-2026年：免疫毒性、全身毒性、発がん性、遺伝子毒性、発生毒性・生殖毒性（DART）、その他 ・In Vivo毒性学の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・In Vivo毒性学のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・In Vivo毒性学のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・In Vivo毒性学の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・In Vivo毒性学の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The In Vivo Toxicology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global In Vivo Toxicology size is estimated to be USD 5315.9 million in 2026 from USD 4315.8 million in 2020, with a change XX% between 2020 and 2021. The global In Vivo Toxicology market size is expected to grow at a CAGR of 5.3% for the next five years.
Market segmentation
In Vivo Toxicology market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chronic Toxicity Testing
Sub-Chronic Toxicity Testing
Sub-Acute Toxicity Testing
Acute Toxicity Testing
Market segment by Application, can be divided into
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental and Reproductive Toxicity(DART)
Other Toxicity Endpoints
Market segment by players, this report covers
Thermo Fisher Scientific
Danaher
Charles River Laboratories
Labcorp
The Jackson Laboratory
Data Sciences International
Envigo
Eurofins Scientific
Perkinelmer
SRI International
Taconic Biosciences
Wuxi Apptec
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe In Vivo Toxicology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of In Vivo Toxicology, with revenue, gross margin and global market share of In Vivo Toxicology from 2019 to 2021.
Chapter 3, the In Vivo Toxicology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and In Vivo Toxicology market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe In Vivo Toxicology research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of In Vivo Toxicology
1.2 Classification of In Vivo Toxicology by Type
1.2.1 Overview: Global In Vivo Toxicology Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global In Vivo Toxicology Revenue Market Share by Type in 2020
1.2.3 Chronic Toxicity Testing
1.2.4 Sub-Chronic Toxicity Testing
1.2.5 Sub-Acute Toxicity Testing
1.2.6 Acute Toxicity Testing
1.3 Global In Vivo Toxicology Market by Application
1.3.1 Overview: Global In Vivo Toxicology Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Immunotoxicity
1.3.3 Systemic Toxicity
1.3.4 Carcinogenicity
1.3.5 Genotoxicity
1.3.6 Developmental and Reproductive Toxicity(DART)
1.3.7 Other Toxicity Endpoints
1.4 Global In Vivo Toxicology Market Size & Forecast
1.5 Global In Vivo Toxicology Market Size and Forecast by Region
1.5.1 Global In Vivo Toxicology Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global In Vivo Toxicology Market Size by Region, (2016-2021)
1.5.3 North America In Vivo Toxicology Market Size and Prospect (2016-2026)
1.5.4 Europe In Vivo Toxicology Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific In Vivo Toxicology Market Size and Prospect (2016-2026)
1.5.6 South America In Vivo Toxicology Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa In Vivo Toxicology Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 In Vivo Toxicology Market Drivers
1.6.2 In Vivo Toxicology Market Restraints
1.6.3 In Vivo Toxicology Trends Analysis
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific In Vivo Toxicology Product and Solutions
2.1.4 Thermo Fisher Scientific In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business
2.2.3 Danaher In Vivo Toxicology Product and Solutions
2.2.4 Danaher In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Danaher Recent Developments and Future Plans
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business
2.3.3 Charles River Laboratories In Vivo Toxicology Product and Solutions
2.3.4 Charles River Laboratories In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Charles River Laboratories Recent Developments and Future Plans
2.4 Labcorp
2.4.1 Labcorp Details
2.4.2 Labcorp Major Business
2.4.3 Labcorp In Vivo Toxicology Product and Solutions
2.4.4 Labcorp In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Labcorp Recent Developments and Future Plans
2.5 The Jackson Laboratory
2.5.1 The Jackson Laboratory Details
2.5.2 The Jackson Laboratory Major Business
2.5.3 The Jackson Laboratory In Vivo Toxicology Product and Solutions
2.5.4 The Jackson Laboratory In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 The Jackson Laboratory Recent Developments and Future Plans
2.6 Data Sciences International
2.6.1 Data Sciences International Details
2.6.2 Data Sciences International Major Business
2.6.3 Data Sciences International In Vivo Toxicology Product and Solutions
2.6.4 Data Sciences International In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Data Sciences International Recent Developments and Future Plans
2.7 Envigo
2.7.1 Envigo Details
2.7.2 Envigo Major Business
2.7.3 Envigo In Vivo Toxicology Product and Solutions
2.7.4 Envigo In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Envigo Recent Developments and Future Plans
2.8 Eurofins Scientific
2.8.1 Eurofins Scientific Details
2.8.2 Eurofins Scientific Major Business
2.8.3 Eurofins Scientific In Vivo Toxicology Product and Solutions
2.8.4 Eurofins Scientific In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Eurofins Scientific Recent Developments and Future Plans
2.9 Perkinelmer
2.9.1 Perkinelmer Details
2.9.2 Perkinelmer Major Business
2.9.3 Perkinelmer In Vivo Toxicology Product and Solutions
2.9.4 Perkinelmer In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Perkinelmer Recent Developments and Future Plans
2.10 SRI International
2.10.1 SRI International Details
2.10.2 SRI International Major Business
2.10.3 SRI International In Vivo Toxicology Product and Solutions
2.10.4 SRI International In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 SRI International Recent Developments and Future Plans
2.11 Taconic Biosciences
2.11.1 Taconic Biosciences Details
2.11.2 Taconic Biosciences Major Business
2.11.3 Taconic Biosciences In Vivo Toxicology Product and Solutions
2.11.4 Taconic Biosciences In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Taconic Biosciences Recent Developments and Future Plans
2.12 Wuxi Apptec
2.12.1 Wuxi Apptec Details
2.12.2 Wuxi Apptec Major Business
2.12.3 Wuxi Apptec In Vivo Toxicology Product and Solutions
2.12.4 Wuxi Apptec In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Wuxi Apptec Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In Vivo Toxicology Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 In Vivo Toxicology Players Market Share
3.2.2 Top 10 In Vivo Toxicology Players Market Share
3.2.3 Market Competition Trend
3.3 In Vivo Toxicology Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global In Vivo Toxicology Revenue and Market Share by Type (2016-2021)
4.2 Global In Vivo Toxicology Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global In Vivo Toxicology Revenue Market Share by Application (2016-2021)
5.2 In Vivo Toxicology Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America In Vivo Toxicology Revenue by Type (2016-2026)
6.2 North America In Vivo Toxicology Revenue by Application (2016-2026)
6.3 North America In Vivo Toxicology Market Size by Country
6.3.1 North America In Vivo Toxicology Revenue by Country (2016-2026)
6.3.2 United States In Vivo Toxicology Market Size and Forecast (2016-2026)
6.3.3 Canada In Vivo Toxicology Market Size and Forecast (2016-2026)
6.3.4 Mexico In Vivo Toxicology Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe In Vivo Toxicology Revenue by Type (2016-2026)
7.2 Europe In Vivo Toxicology Revenue by Application (2016-2026)
7.3 Europe In Vivo Toxicology Market Size by Country
7.3.1 Europe In Vivo Toxicology Revenue by Country (2016-2026)
7.3.2 Germany In Vivo Toxicology Market Size and Forecast (2016-2026)
7.3.3 France In Vivo Toxicology Market Size and Forecast (2016-2026)
7.3.4 United Kingdom In Vivo Toxicology Market Size and Forecast (2016-2026)
7.3.5 Russia In Vivo Toxicology Market Size and Forecast (2016-2026)
7.3.6 Italy In Vivo Toxicology Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific In Vivo Toxicology Revenue by Type (2016-2026)
8.2 Asia-Pacific In Vivo Toxicology Revenue by Application (2016-2026)
8.3 Asia-Pacific In Vivo Toxicology Market Size by Region
8.3.1 Asia-Pacific In Vivo Toxicology Revenue by Region (2016-2026)
8.3.2 China In Vivo Toxicology Market Size and Forecast (2016-2026)
8.3.3 Japan In Vivo Toxicology Market Size and Forecast (2016-2026)
8.3.4 South Korea In Vivo Toxicology Market Size and Forecast (2016-2026)
8.3.5 India In Vivo Toxicology Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia In Vivo Toxicology Market Size and Forecast (2016-2026)
8.3.7 Australia In Vivo Toxicology Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America In Vivo Toxicology Revenue by Type (2016-2026)
9.2 South America In Vivo Toxicology Revenue by Application (2016-2026)
9.3 South America In Vivo Toxicology Market Size by Country
9.3.1 South America In Vivo Toxicology Revenue by Country (2016-2026)
9.3.2 Brazil In Vivo Toxicology Market Size and Forecast (2016-2026)
9.3.3 Argentina In Vivo Toxicology Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa In Vivo Toxicology Revenue by Type (2016-2026)
10.2 Middle East & Africa In Vivo Toxicology Revenue by Application (2016-2026)
10.3 Middle East & Africa In Vivo Toxicology Market Size by Country
10.3.1 Middle East & Africa In Vivo Toxicology Revenue by Country (2016-2026)
10.3.2 Turkey In Vivo Toxicology Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia In Vivo Toxicology Market Size and Forecast (2016-2026)
10.3.4 UAE In Vivo Toxicology Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global In Vivo Toxicology Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global In Vivo Toxicology Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market In Vivo Toxicology Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global In Vivo Toxicology Revenue (USD Million) by Region (2016-2021)
Table 5. Global In Vivo Toxicology Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific In Vivo Toxicology Product and Solutions
Table 9. Thermo Fisher Scientific In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Danaher Corporate Information, Head Office, and Major Competitors
Table 11. Danaher Major Business
Table 12. Danaher In Vivo Toxicology Product and Solutions
Table 13. Danaher In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Charles River Laboratories Major Business
Table 16. Charles River Laboratories In Vivo Toxicology Product and Solutions
Table 17. Charles River Laboratories In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Labcorp Corporate Information, Head Office, and Major Competitors
Table 19. Labcorp Major Business
Table 20. Labcorp In Vivo Toxicology Product and Solutions
Table 21. Labcorp In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. The Jackson Laboratory Corporate Information, Head Office, and Major Competitors
Table 23. The Jackson Laboratory Major Business
Table 24. The Jackson Laboratory In Vivo Toxicology Product and Solutions
Table 25. The Jackson Laboratory In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Data Sciences International Corporate Information, Head Office, and Major Competitors
Table 27. Data Sciences International Major Business
Table 28. Data Sciences International In Vivo Toxicology Product and Solutions
Table 29. Data Sciences International In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Envigo Corporate Information, Head Office, and Major Competitors
Table 31. Envigo Major Business
Table 32. Envigo In Vivo Toxicology Product and Solutions
Table 33. Envigo In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 35. Eurofins Scientific Major Business
Table 36. Eurofins Scientific In Vivo Toxicology Product and Solutions
Table 37. Eurofins Scientific In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Perkinelmer Corporate Information, Head Office, and Major Competitors
Table 39. Perkinelmer Major Business
Table 40. Perkinelmer In Vivo Toxicology Product and Solutions
Table 41. Perkinelmer In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. SRI International Corporate Information, Head Office, and Major Competitors
Table 43. SRI International Major Business
Table 44. SRI International In Vivo Toxicology Product and Solutions
Table 45. SRI International In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Taconic Biosciences Corporate Information, Head Office, and Major Competitors
Table 47. Taconic Biosciences Major Business
Table 48. Taconic Biosciences In Vivo Toxicology Product and Solutions
Table 49. Taconic Biosciences In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Wuxi Apptec Corporate Information, Head Office, and Major Competitors
Table 51. Wuxi Apptec Major Business
Table 52. Wuxi Apptec In Vivo Toxicology Product and Solutions
Table 53. Wuxi Apptec In Vivo Toxicology Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global In Vivo Toxicology Revenue (USD Million) by Players (2019-2021)
Table 55. Global In Vivo Toxicology Revenue Share by Players (2019-2021)
Table 56. Breakdown of In Vivo Toxicology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. In Vivo Toxicology Players Head Office, Products and Services Provided
Table 58. In Vivo Toxicology Mergers & Acquisitions in the Past Five Years
Table 59. In Vivo Toxicology New Entrants and Expansion Plans
Table 60. Global In Vivo Toxicology Revenue (USD Million) by Type (2016-2021)
Table 61. Global In Vivo Toxicology Revenue Share by Type (2016-2021)
Table 62. Global In Vivo Toxicology Revenue Forecast by Type (2021-2026)
Table 63. Global In Vivo Toxicology Revenue by Application (2016-2021)
Table 64. Global In Vivo Toxicology Revenue Forecast by Application (2021-2026)
Table 65. North America In Vivo Toxicology Revenue by Type (2016-2021) & (USD Million)
Table 66. North America In Vivo Toxicology Revenue by Type (2021-2026) & (USD Million)
Table 67. North America In Vivo Toxicology Revenue by Application (2016-2021) & (USD Million)
Table 68. North America In Vivo Toxicology Revenue by Application (2021-2026) & (USD Million)
Table 69. North America In Vivo Toxicology Revenue by Country (2016-2021) & (USD Million)
Table 70. North America In Vivo Toxicology Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe In Vivo Toxicology Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe In Vivo Toxicology Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe In Vivo Toxicology Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe In Vivo Toxicology Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe In Vivo Toxicology Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe In Vivo Toxicology Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific In Vivo Toxicology Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific In Vivo Toxicology Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific In Vivo Toxicology Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific In Vivo Toxicology Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific In Vivo Toxicology Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific In Vivo Toxicology Revenue by Region (2021-2026) & (USD Million)
Table 83. South America In Vivo Toxicology Revenue by Type (2016-2021) & (USD Million)
Table 84. South America In Vivo Toxicology Revenue by Type (2021-2026) & (USD Million)
Table 85. South America In Vivo Toxicology Revenue by Application (2016-2021) & (USD Million)
Table 86. South America In Vivo Toxicology Revenue by Application (2021-2026) & (USD Million)
Table 87. South America In Vivo Toxicology Revenue by Country (2016-2021) & (USD Million)
Table 88. South America In Vivo Toxicology Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa In Vivo Toxicology Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa In Vivo Toxicology Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa In Vivo Toxicology Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa In Vivo Toxicology Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa In Vivo Toxicology Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa In Vivo Toxicology Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. In Vivo Toxicology Picture
Figure 2. Global In Vivo Toxicology Revenue Market Share by Type in 2020
Figure 3. Chronic Toxicity Testing
Figure 4. Sub-Chronic Toxicity Testing
Figure 5. Sub-Acute Toxicity Testing
Figure 6. Acute Toxicity Testing
Figure 7. In Vivo Toxicology Revenue Market Share by Application in 2020
Figure 8. Immunotoxicity Picture
Figure 9. Systemic Toxicity Picture
Figure 10. Carcinogenicity Picture
Figure 11. Genotoxicity Picture
Figure 12. Developmental and Reproductive Toxicity(DART) Picture
Figure 13. Other Toxicity Endpoints Picture
Figure 14. Global In Vivo Toxicology Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global In Vivo Toxicology Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global In Vivo Toxicology Revenue Market Share by Region (2016-2026)
Figure 17. Global In Vivo Toxicology Revenue Market Share by Region in 2020
Figure 18. North America In Vivo Toxicology Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe In Vivo Toxicology Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific In Vivo Toxicology Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America In Vivo Toxicology Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa In Vivo Toxicology Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. In Vivo Toxicology Market Drivers
Figure 24. In Vivo Toxicology Market Restraints
Figure 25. In Vivo Toxicology Market Trends
Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 27. Danaher Recent Developments and Future Plans
Figure 28. Charles River Laboratories Recent Developments and Future Plans
Figure 29. Labcorp Recent Developments and Future Plans
Figure 30. The Jackson Laboratory Recent Developments and Future Plans
Figure 31. Data Sciences International Recent Developments and Future Plans
Figure 32. Envigo Recent Developments and Future Plans
Figure 33. Eurofins Scientific Recent Developments and Future Plans
Figure 34. Perkinelmer Recent Developments and Future Plans
Figure 35. SRI International Recent Developments and Future Plans
Figure 36. Taconic Biosciences Recent Developments and Future Plans
Figure 37. Wuxi Apptec Recent Developments and Future Plans
Figure 38. Global In Vivo Toxicology Revenue Share by Players in 2020
Figure 39. In Vivo Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players In Vivo Toxicology Revenue Market Share in 2020
Figure 41. Global Top 10 Players In Vivo Toxicology Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global In Vivo Toxicology Revenue Share by Type in 2020
Figure 44. Global In Vivo Toxicology Market Share Forecast by Type (2021-2026)
Figure 45. Global In Vivo Toxicology Revenue Share by Application in 2020
Figure 46. Global In Vivo Toxicology Market Share Forecast by Application (2021-2026)
Figure 47. North America In Vivo Toxicology Sales Market Share by Type (2016-2026)
Figure 48. North America In Vivo Toxicology Sales Market Share by Application (2016-2026)
Figure 49. North America In Vivo Toxicology Revenue Market Share by Country (2016-2026)
Figure 50. United States In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe In Vivo Toxicology Sales Market Share by Type (2016-2026)
Figure 54. Europe In Vivo Toxicology Sales Market Share by Application (2016-2026)
Figure 55. Europe In Vivo Toxicology Revenue Market Share by Country (2016-2026)
Figure 56. Germany In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific In Vivo Toxicology Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific In Vivo Toxicology Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific In Vivo Toxicology Revenue Market Share by Region (2016-2026)
Figure 64. China In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America In Vivo Toxicology Sales Market Share by Type (2016-2026)
Figure 71. South America In Vivo Toxicology Sales Market Share by Application (2016-2026)
Figure 72. South America In Vivo Toxicology Revenue Market Share by Country (2016-2026)
Figure 73. Brazil In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa In Vivo Toxicology Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa In Vivo Toxicology Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa In Vivo Toxicology Revenue Market Share by Country (2016-2026)
Figure 78. Turkey In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE In Vivo Toxicology Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の毒物学試験サービス市場予測（～2024年） Increase in demand for detection of toxicity of products during their early stages of development, rise in R&D expenditure, growing preference for outsourcing of toxicological studies to contract research organizations, rise in consumer awareness about safety associated with the use of health care a…- 世界の遺伝毒性試験市場 2021：企業別、地域別、種類・用途別 The Genetic Toxicology Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の通信家電市場 2021：企業別、地域別、種類・用途別 The Communications Consumer Electronics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の薬物検査システム市場予測（～2024年） Drug testing diagnostics for detection of drugs-of-abuse and therapeutic drug monitoring. Scope of the Report: The worldwide market for Drug Testing System is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according…
- 世界のゲーム用電話市場 2021：企業別、地域別、種類・用途別 The Gaming Phone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…